Comparative effectiveness and costs of generic and brand-name gabapentin and venlafaxine in patients with neuropathic pain or generalized anxiety disorder in Spain-Reference-Cited by-同舟云学术

Comparative effectiveness and costs of generic and brand-name gabapentin and venlafaxine in patients with neuropathic pain or generalized anxiety disorder in Spain

Published:2015-06 Issue: Volume: Page:299
ISSN:1178-6981
Container-title:ClinicoEconomics and Outcomes Research
language:en
Short-container-title:CEOR

Author:

Rejas Javier,Sicras-Mainar Antoni,Navarro-Artieda Ruth

Publisher

Informa UK Limited

Subject

Health Policy,Economics, Econometrics and Finance (miscellaneous)

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Brand-Name and Generic Versions of Glimepiride for Diabetes Mellitus Care: Experience at a Medical Center in Taiwan;INT J GERONTOL;2019

2. Switching medication products during the treatment of psychiatric illness;International Journal of Psychiatry in Clinical Practice;2019-01-02

3. Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis;Lipids in Health and Disease;2018-12

4. Consequences on economic outcomes of generic versus brand-name drugs used in routine clinical practice: the case of treating peripheral neuropathic pain or generalized anxiety disorder with pregabalin;Expert Review of Pharmacoeconomics & Outcomes Research;2018-09-17

5. Efecto de la edad y el género sobre las consecuencias clínicas y económicas del tratamiento con especialidad farmacéutica de marca o genérica en pacientes con dolor neuropático periférico en práctica clínica habitual;Neurología;2018-04